Inventor · disambiguated record
Chuan He
Also filed as: HE CHUAN · HE CHUAN HUA
21 granted patents·22 pending applications·146 citations·filing 2007–2025
93Inventor score
Top patents by PatentIndex Score
43 records- 0196US8741567B2Composition and methods related to modification of 5-hydroxymethylcytosine (5-hmC)HE CHUAN·Filed 2011·Granted Jun 3, 2014·62 cites·25 claims
- 0295US10253111B2Methods and compositions relating to anti-Chi3l1 antibody reagentsUNIV BROWN·Filed 2018·Granted Apr 9, 2019·12 cites·14 claims
- 0394US9175348B2Identification of 5-methyl-C in nucleic acid templatesPACIFIC BIOSCIENCES CALIFORNIA·Filed 2013·Granted Nov 3, 2015·31 cites·13 claims
- 0493US9611510B2Composition and methods related to modification of 5-methylcytosine (5-mC)HE CHUAN·Filed 2012·Granted Apr 4, 2017·27 cites·10 claims
- 0590US10766968B2Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancerUNIV BROWN·Filed 2018·Granted Sep 8, 2020·5 cites·8 claims
- 0688US11905555B2Methods for the amplification of bisulfite-treated DNAUNIV CHICAGO·Filed 2022·Granted Feb 20, 2024·2 cites·18 claims
- 0785US11512322B2Transgenic plant and the method for producing the sameEPIPLANTA BIOTECH LTD·Filed 2021·Granted Nov 29, 2022·1 cites·20 claims
- 0883US11046969B2Transgenic plant and the method for producing the sameEPIPLANTA BIOTECH LTD·Filed 2017·Granted Jun 29, 2021·2 cites·10 claims
- 0980US2024318193A1Transgenic plant and the method for producing the sameEPIPLANTA BIOTECH LTD·Filed 2023·Application pending·0 cites
- 1080US2023406958A1Methods and compositions relating to anti-chi3l1 antibody reagentsUNIV BROWN·Filed 2023·Application pending·0 cites
- 1179US12428666B2Compositions and methods related to kethoxal derivativesUNIV CHICAGO·Filed 2019·Granted Sep 30, 2025·1 cites·15 claims
- 1279US11891610B2Transgenic plant and the method for producing the sameEPIPLANTA BIOTECH LTD·Filed 2022·Granted Feb 6, 2024·0 cites·10 claims
- 1378US11130991B2Method for highly sensitive DNA methylation analysisUNIV CHICAGO·Filed 2018·Granted Sep 28, 2021·1 cites·22 claims
- 1478US2025092449A1Method for highly sensitive dna methylation analysisUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 1577US10752700B2Methods and compositions relating to anti-CHI3L1 antibody reagents to treat nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NFALD) or metabolic syndromeUNIV BROWN·Filed 2018·Granted Aug 25, 2020·1 cites·10 claims
- 1674US2020102616A1COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5 HYDROXYMETHYLCYTOSINE (5-hmC)UNIV CHICAGO·Filed 2019·Application pending·0 cites
- 1771US12188084B2Method for highly sensitive DNA methylation analysisUNIV CHICAGO·Filed 2021·Granted Jan 7, 2025·0 cites·19 claims
- 1871US9255019B2Protein scaffolds for selective enrichment of metal ionsUNIV CHICAGO·Filed 2013·Granted Feb 9, 2016·1 cites·20 claims
- 1971US2025195570A1Methods and compositions for cancer therapyUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 2070US11667725B2Methods and compositions relating to anti-CHI3L1 antibody reagents for the treatment of cancerUNIV BROWN·Filed 2020·Granted Jun 6, 2023·0 cites·15 claims
- 2170US2015056616A1COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-HYDROXYMETHYLCYTOSINE (5-hmC)UNIV CHICAGO·Filed 2014·Application pending·0 cites
- 2265US12359242B2Chemical platform assisted proximity capture (CAP-C)UNIV CHICAGO·Filed 2019·Granted Jul 15, 2025·0 cites·25 claims
- 2365US11667726B2Methods and compositions relating to bispecific anti-CHI3L1 antibody reagents for the treatment of cancerUNIV BROWN·Filed 2020·Granted Jun 6, 2023·0 cites·16 claims
- 2464US11530441B2Methods for the amplification of bisulfite-treated DNAUNIV CHICAGO·Filed 2019·Granted Dec 20, 2022·0 cites·22 claims
- 2564US2024076407A1Methods and compositions relating to bispecific anti-chi3l1 antibody reagentsUNIV BROWN·Filed 2023·Application pending·0 cites
- 2663US12227769B2Methods and compositions for treating negative-sense single-stranded RNA virusUNIV CHICAGO·Filed 2019·Granted Feb 18, 2025·0 cites·25 claims
- 2763US2024158778A1Methods for assessing specificity of crispr-mediated genome editingUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 2861US2025000838A1Uses of Inhibitors of YTH Domain Family Proteins in the Management of Cognitive or Developmental DisordersUNIV EMORY·Filed 2022·Application pending·0 cites
- 2961US2025066837A1Methods and compositions for rapid detection and analysis of rna and dna cytosine methylationUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 3057US2025288402A1Methods and compositions for improving fertilityUNIV CHICAGO·Filed 2023·Application pending·0 cites
- 3156US2025154187A1Compositions and methods related to modification and detection of pseudouridine and 5-hydroxymethylcytosineUNIV CHICAGO·Filed 2022·Application pending·0 cites
- 3255US11396672B2Composition and methods for detecting adenosine modificationsUNIV CHICAGO·Filed 2016·Granted Jul 26, 2022·0 cites·16 claims
- 3355US2022364173A1Methods and systems for detection of nucleic acid modificationsUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 3455US2022025004A1Compositions and methods related to site-specific identification of rna modificationsUNIV CHICAGO·Filed 2019·Application pending·0 cites
- 3554US2025250548A1Methods and compositions for treating negative-sense single-stranded rna virusUNIV CHICAGO·Filed 2025·Application pending·0 cites
- 3652US2022143198A1Compositions and methods related to tethered kethoxal derivativesUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 3747US12359200B2Methods and compositions for expansion of cell populationSTOWERS INSTITUTE FOR MEDICAL RES·Filed 2018·Granted Jul 15, 2025·0 cites·12 claims
- 3846US2007248581A1Mgra is a redox regulator of antibiotic sensitivity and virulenceUNIV CHICAGO·Filed 2007·Application pending·0 cites
- 3944US2016074373A1Methods and compositions for inhibiting human copper trafficking proteins atox1 and ccsSHANGHAI INST MATERIA MEDICA·Filed 2014·Application pending·0 cites
- 4044US2021095341A1Multiplex 5mc marker barcode counting for methylation detection in cell free dnaUNIV CHICAGO·Filed 2018·Application pending·0 cites
- 4144US2023123585A1Compositions and methods for treating or preventing cancer using deubiquitinase inhibitorsUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 4243US2025297234A1Engineered rna demethylases for improved plant growthUNIV CHICAGO·Filed 2025·Application pending·0 cites
- 4339US2020190581A1Methods for detecting cytosine modificationsUNIV CHICAGO·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →